Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Marketing "Gifts": How Merck Sold Vioxx

While I was reviewing this awesome piece about Merck's marketing tactics behind pushing Vioxx in today's New York Times, I was struck by the company's strategic use of a physician "hit list," promotional activities and huge amolunts of cash to neutralize its prime competitor, Celebrex. And, I suspect, largely because G.D. Searle's Celebrex beat Merck to the market. The Times obtained a plethora of documents from a public official, including e-mail messages, memorandums and...